{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-010201","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2022-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.188756+00:00","generated_at":"2026-06-25T13:08:04.061612+00:00","sec_items":["5.02","5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Mednax appoints James D. Swift as COO; shareholders reject say-on-pay","bullets":["James D. Swift, MD promoted from EVP/Chief Development Officer to EVP/COO, effective May 12, 2022.","Say-on-pay vote failed: 45.2 million against vs 34.6 million for (56.6% against).","All director nominees elected; Weiss and Starcher each received over 9 million against votes.","Ratification of PwC as auditor for FY2022 passed with 78.3 million votes for.","Shareholders approved Second Amended and Restated Articles of Incorporation."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-010201","json":"https://secwatch.observer/filing/0000950170-22-010201.json","markdown":"https://secwatch.observer/filing/0000950170-22-010201.md","text":"https://secwatch.observer/filing/0000950170-22-010201.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000095017022010201/0000950170-22-010201-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000095017022010201/md-20220512.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T13:08:04.061612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a976fd32bb","claim":"James D. Swift was appointed as Chief Operating Officer at Pediatrix Medical Group, Inc..","evidence_excerpt":"On May 12, 2022, Mednax, Inc., a Florida corporation (the “Company”), appointed James D. Swift, M.D. as an Executive Vice President and the Company’s Chief Operating Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/893949/000095017022010201/0000950170-22-010201-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}